US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 19.880
  • -1.210-5.74%
Close Feb 26 16:00 ET
  • 19.800
  • -0.080-0.40%
Pre 06:26 ET
1.14BMarket Cap-10.30P/E (TTM)

About Structure Therapeutics Company

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.

Company Profile

SymbolGPCR
Company NameStructure Therapeutics
Listing DateFeb 3, 2023
Issue Price15.00
Founded2019
CEOProfessor Raymond C. Stevens, PhD
MarketNASDAQ
Employees93
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address601 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-457-1978
Websitehttp://www.structuretx.com

Company Executives

  • Name
  • Position
  • Salary
  • Professor Raymond C. Stevens, PhD
  • Director and Chief Executive Officer
  • --
  • Jun Yoon
  • Principal Accounting Officer and Chief Financial Officer
  • --
  • Dr. Blai Coll
  • Chief Medical Officer
  • --
  • Dr. Yingli Ma, PhD
  • Chief Technology Officer
  • --
  • Dr. Xichen Lin, PhD
  • Chief Scientific Officer
  • --
  • Ashley F. Hall, J.D.
  • Chief Development Officer
  • --
  • Daniel G. Welch
  • Chairman of the Board
  • --
  • Dr. Ted W. Love, M.D.
  • Independent Director
  • --
  • Angus Charles Russell
  • Independent Director
  • --
  • Sharon E. Tetlow
  • Independent Director
  • --
  • Eric L. Dobmeier
  • Independent Director
  • --
  • Dr. Joanne Waldstreicher, M.D.
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
HENDERA
831152
+29.97%
LINGOOD
833284
+29.95%
4
WUHAN LAND
830779
+25.43%
5
TECHVISION
832876
+21.28%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!